Subscribe to Vendors

Vendors

Flexicare enters U.S. ostomy market

 - 
04/10/2012

IRVINE, Calif. – After several years of feeling out the United States, Flexicare, a medical device company based in the U.K., has now targeted the homecare market and has set up an official outpost for its ostomy and continence business here.

CMS: One step closer to dropping certain TENS coverage

 - 
03/30/2012

BALTIMORE - Transcutaneous electrical nerve stimulation (TENS) for chronic lower back pain now has two strikes against it.

Device tax: HME manufacturers strategize

 - 
03/30/2012

WASHINGTON - Will HME manufacturers spread the pain of a 2.3% excise tax on medical devices?

Roscoe targets TENS

 - 
03/27/2012

STRONGSVILLE, Ohio – Roscoe Medical considers transcutaneous electrical nerve stimulation or TENS an “undercover” product offering in the HME industry, but with a recent acquisition, it hopes to change that.

Briefs: GF buys maker of support surfaces

 - 
03/27/2012

ATLANTA - GF Health Products announced in March that it planned to acquire "substantially all of the assets" of Pressure Management Group, a Jacksonville, Fla.-based, privately-owned manufacturer of pressure reduction support surfaces, gel overlays, mattresses, foam and g

Case Study: Beds

 - 
03/27/2012

PORTLAND, Maine - The margins on specialty mattresses and adjustable beds are attractive for cash-strapped HME providers, but Jim Greatorex says, for him, they haven't been "huge movers" yet.

FDA also warns GF, Merits

 - 
03/09/2012

YARMOUTH, Maine - It looks like the U.S. Food and Drug Administration (FDA) has its eyes on more than just Invacare.

U-Sleep simplifies compliance

 - 
03/09/2012

HALIFAX, N.S. - A new software program called U-Sleep allows HME providers to obtain and manage compliance data from any of the major CPAP devices using one web-based, HIPAA-compliant tool.

Product design and marketing unite

 - 
02/28/2012

MUNDELEIN, Ill. – Rich Derks, the new president of Medline’s DME Division is the total package: He has an undergraduate degree in engineering and an MBA in marketing.

ResMed spends big on R&D

 - 
02/27/2012

SAN DIEGO - ResMed in January reported $332.7 million in revenue for the second quarter ended Dec. 31, 2011, a 9% increase compared to the same quarter in 2010. It reported a net income of $62.9 million, an 8% increase.

Pages